CR20160562A - Péptidos como agonistas de la oxitocina - Google Patents
Péptidos como agonistas de la oxitocinaInfo
- Publication number
- CR20160562A CR20160562A CR20160562A CR20160562A CR20160562A CR 20160562 A CR20160562 A CR 20160562A CR 20160562 A CR20160562 A CR 20160562A CR 20160562 A CR20160562 A CR 20160562A CR 20160562 A CR20160562 A CR 20160562A
- Authority
- CR
- Costa Rica
- Prior art keywords
- oxychocine
- agonists
- peptides
- lower alkyl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
La invención se refiere a compuestos de fórmula en donde R1 es hidrógeno, alquilo inferior, -CH2-cicloalquilo o cicloalquilo; R2 es hidrógeno, alquilo inferior, alquilo inferior sustituido con hidroxi, o R1 y R2 pueden formar junto con el átomo de N y C al que están unidos un anillo de pirrolidina opcionalmente sustituido con uno o dos átomos de F o con hidroxi, o puede formar una azetidina o un anillo de piperidina;
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14171440 | 2014-06-06 | ||
PCT/EP2015/062314 WO2015185584A1 (en) | 2014-06-06 | 2015-06-03 | Peptides as oxytocin agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20160562A true CR20160562A (es) | 2017-01-06 |
Family
ID=50932985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20160562A CR20160562A (es) | 2014-06-06 | 2014-06-06 | Péptidos como agonistas de la oxitocina |
Country Status (16)
Country | Link |
---|---|
US (1) | US20170081368A1 (es) |
EP (1) | EP3152225B1 (es) |
JP (1) | JP6535688B2 (es) |
KR (1) | KR20170004014A (es) |
CN (1) | CN106459156A (es) |
AU (1) | AU2015270564A1 (es) |
CA (1) | CA2950493A1 (es) |
CL (1) | CL2016003076A1 (es) |
CR (1) | CR20160562A (es) |
EA (1) | EA030296B1 (es) |
IL (1) | IL248625A0 (es) |
MX (1) | MX2016015877A (es) |
PE (1) | PE20170427A1 (es) |
PH (1) | PH12016502251A1 (es) |
SG (1) | SG11201610221WA (es) |
WO (1) | WO2015185584A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS65144B1 (sr) | 2014-09-19 | 2024-02-29 | Ferring Bv | Postupak za lečenje prader-vilijevog sindroma |
US20190135859A1 (en) | 2017-08-11 | 2019-05-09 | Ferring B.V. | Method of manufacturing a pharmaceutical composition |
CN110997697A (zh) | 2017-08-11 | 2020-04-10 | 辉凌公司 | 制备药物组合物的方法 |
AU2019345313A1 (en) | 2018-09-20 | 2021-03-18 | Levo Therapeutics, Inc. | Carbetocin drug product and process for preparing same |
US20200093884A1 (en) | 2018-09-20 | 2020-03-26 | Mark C. Manning | Stable intranasal formulations of carbetocin |
CN113801200B (zh) * | 2021-09-28 | 2023-07-25 | 浙江湃肽生物有限公司 | 一种卡贝缩宫素的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4483794A (en) * | 1983-05-10 | 1984-11-20 | Ceskoslovenska Akademie Ved | Analogs of neurohypophysial hormones |
KR20070022753A (ko) * | 2004-05-26 | 2007-02-27 | 화이자 인코포레이티드 | 인다졸 및 인돌론 유도체 및 이의 약제로서의 용도 |
FR2875499B1 (fr) * | 2004-09-20 | 2006-10-27 | Sanofi Aventis Sa | Nouveaux derives pyridiniques d'indolin-2-one, leur preparation et leur application en therapeutique |
CN101641013B (zh) * | 2007-01-22 | 2014-07-30 | Gtx公司 | 核受体结合剂 |
CA2718148C (en) * | 2008-03-31 | 2017-11-07 | Ferring B.V. | Oxytocin analogues |
BRPI0919342A2 (pt) * | 2008-09-23 | 2015-12-29 | Hoffmann La Roche | derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu uso |
KR101701533B1 (ko) * | 2009-05-05 | 2017-02-13 | 에프. 호프만-라 로슈 아게 | 아이속사졸-피리다진 유도체 |
TWI463990B (zh) * | 2009-09-21 | 2014-12-11 | Ferring Bv | 催產素受體促進劑 |
ES2509270T3 (es) * | 2009-10-01 | 2014-10-17 | The University Of Sydney | Terapia y prevención del alcoholismo |
US9585935B2 (en) | 2010-07-30 | 2017-03-07 | The Regents Of The University Of California | Intranasal oxytocin treatment to improve schizophrenia |
-
2014
- 2014-06-06 CR CR20160562A patent/CR20160562A/es unknown
-
2015
- 2015-06-03 KR KR1020167036061A patent/KR20170004014A/ko not_active Application Discontinuation
- 2015-06-03 CA CA2950493A patent/CA2950493A1/en not_active Abandoned
- 2015-06-03 EA EA201692488A patent/EA030296B1/ru not_active IP Right Cessation
- 2015-06-03 MX MX2016015877A patent/MX2016015877A/es unknown
- 2015-06-03 WO PCT/EP2015/062314 patent/WO2015185584A1/en active Application Filing
- 2015-06-03 JP JP2016571215A patent/JP6535688B2/ja not_active Expired - Fee Related
- 2015-06-03 EP EP15725069.7A patent/EP3152225B1/en not_active Not-in-force
- 2015-06-03 SG SG11201610221WA patent/SG11201610221WA/en unknown
- 2015-06-03 PE PE2016002273A patent/PE20170427A1/es unknown
- 2015-06-03 AU AU2015270564A patent/AU2015270564A1/en not_active Abandoned
- 2015-06-03 CN CN201580028538.6A patent/CN106459156A/zh active Pending
-
2016
- 2016-10-30 IL IL248625A patent/IL248625A0/en unknown
- 2016-11-11 PH PH12016502251A patent/PH12016502251A1/en unknown
- 2016-11-29 CL CL2016003076A patent/CL2016003076A1/es unknown
- 2016-12-05 US US15/368,902 patent/US20170081368A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3152225A1 (en) | 2017-04-12 |
JP2017518313A (ja) | 2017-07-06 |
CA2950493A1 (en) | 2015-12-10 |
SG11201610221WA (en) | 2017-01-27 |
IL248625A0 (en) | 2017-01-31 |
WO2015185584A1 (en) | 2015-12-10 |
JP6535688B2 (ja) | 2019-06-26 |
MX2016015877A (es) | 2017-03-27 |
EA201692488A1 (ru) | 2017-05-31 |
CN106459156A (zh) | 2017-02-22 |
AU2015270564A1 (en) | 2016-11-17 |
PH12016502251A1 (en) | 2017-02-06 |
US20170081368A1 (en) | 2017-03-23 |
KR20170004014A (ko) | 2017-01-10 |
EP3152225B1 (en) | 2018-11-14 |
CL2016003076A1 (es) | 2017-08-11 |
EA030296B1 (ru) | 2018-07-31 |
PE20170427A1 (es) | 2017-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20160562A (es) | Péptidos como agonistas de la oxitocina | |
ECSP17073191A (es) | Compuestos heterocíclicos como inhibidores de lsd1 | |
CU20160162A7 (es) | Derivados de pirrolidina-2,5-diona,para usar como inhibidores ido1 y composiciones farmacéuticas que los contienen | |
DOP2016000144A (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
UY34825A (es) | Síntesis de compuestos heterocíclicos | |
CU24411B1 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos | |
BR112015027432B8 (pt) | 3-(4-isobutil-2-metilfenil)propanal como ingrediente de perfume | |
PE20160608A1 (es) | Compuestos de quinolina selectivamente sustituida | |
CU20180144A7 (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos | |
CR20150271A (es) | Peptidos como agonistas de oxitocina | |
PE20210549A1 (es) | Derivado de amino-metil piperidina como inhibidor de quinasa | |
EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
CR20160198A (es) | Derivados de etinilo-imidazolidín-2, 4-diona como moduladore mglur4 | |
UY35333A (es) | Compuestos de azabencimidazol | |
UY35143A (es) | Derivados de dihidropirazol como moduladores del receptor acoplado a la proteína gpr40 g | |
UY35305A (es) | Compuestos sustituidos como moduladores de la pro teína de activación de la 5-lipoxigenasa (flap) | |
DOP2016000242A (es) | Uso de compuestos heterocíclicos para controlar nematodos | |
CR20160448A (es) | Nuevos derivados de piridina | |
BR112015022162A2 (pt) | sonda fluorescente de zinco | |
CR20150417A (es) | Compuestos de azetidiniloxifenilpirrolidina | |
ES2572052T3 (es) | Amidas macrocíclicas como inhibidores de proteasas | |
BR112016028022A2 (pt) | compostos de sulfonamida e seus usos como inibidores de stat5 | |
CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
PE20161559A1 (es) | Peptidos como agonistas de la oxitocina |